Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.
NCT07081607
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Peripheral T-Cell Lymphoma, Not Classified
Interventions
DRUG:
golidocitinib with azacytidine and chidamide
Sponsor
Ruijin Hospital